Cargando…
Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy
Older people represent the fastest growing group with epilepsy diagnosis. For example, cerebrovascular disease may underlie roughly 30–50% of epilepsy in older adults and seizures are also an underrecognized comorbidity of Alzheimer's disease (AD). As a result, up to 10% of nursing home residen...
Autores principales: | del Pozo, Aaron, Lehmann, Leanne, Knox, Kevin M., Barker-Haliski, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096090/ https://www.ncbi.nlm.nih.gov/pubmed/35572927 http://dx.doi.org/10.3389/fneur.2022.833624 |
Ejemplares similares
-
Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation
por: Lehmann, Leanne, et al.
Publicado: (2021) -
Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model
por: Lehmann, Leanne M., et al.
Publicado: (2023) -
Epilepsy Genetics and Precision Medicine in Adults: A New Landscape for Developmental and Epileptic Encephalopathies
por: Beltrán-Corbellini, Álvaro, et al.
Publicado: (2022) -
Diurnal burden of spontaneous seizures in early epileptogenesis in the post‐kainic acid rat model of epilepsy
por: Mizuno, Stephanie, et al.
Publicado: (2021) -
Editorial: Genetically determined epilepsies: Perspectives in the era of precision medicine
por: Mastrangelo, Mario, et al.
Publicado: (2022)